Rationale and design of a cluster randomized trial of a multifaceted intervention in people with hypertension: The Heart Outcomes Prevention and Evaluation 4 (HOPE-4) Study.

[1]  S. Yusuf,et al.  Development, Testing, and Implementation of a Training Curriculum for Nonphysician Health Workers to Reduce Cardiovascular Disease , 2018, Global heart.

[2]  M. Delgado-Rodríguez,et al.  Systematic review and meta-analysis. , 2017, Medicina intensiva.

[3]  Dan J Stein,et al.  Global, regional, and national disability-adjusted life-years (DALYs) for 333 diseases and injuries and healthy life expectancy (HALE) for 195 countries and territories, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016 , 2017, Lancet.

[4]  Mohammad Hossein Khosravi,et al.  Global, regional, and national age-sex specific mortality for 264 causes of death, 1980–2016: a systematic analysis for the Global Burden of Disease Study 2016 , 2017, Lancet.

[5]  Salim Yusuf,et al.  Effective approaches to address the global cardiovascular disease burden , 2017, Current opinion in cardiology.

[6]  S. Yusuf,et al.  Availability and affordability of blood pressure-lowering medicines and the effect on blood pressure control in high-income, middle-income, and low-income countries: an analysis of the PURE study data. , 2017, The Lancet. Public health.

[7]  Sumeet Gandhi,et al.  Effect of Mobile Health Interventions on the Secondary Prevention of Cardiovascular Disease: Systematic Review and Meta-analysis. , 2016, The Canadian journal of cardiology.

[8]  S. Yusuf,et al.  Cholesterol Lowering in Intermediate-Risk Persons without Cardiovascular Disease. , 2016, The New England journal of medicine.

[9]  S. Yusuf,et al.  Blood-Pressure Lowering in Intermediate-Risk Persons without Cardiovascular Disease. , 2016, The New England journal of medicine.

[10]  S. Yusuf,et al.  Blood-Pressure and Cholesterol Lowering in Persons without Cardiovascular Disease. , 2016, The New England journal of medicine.

[11]  S. Yusuf,et al.  Resource Effective Strategies to Prevent and Treat Cardiovascular Disease. , 2016, Circulation.

[12]  S. Yusuf,et al.  Availability and affordability of cardiovascular disease medicines and their effect on use in high-income, middle-income, and low-income countries: an analysis of the PURE study data , 2016, The Lancet.

[13]  S. Yusuf,et al.  Understanding the modifiable health systems barriers to hypertension management in Malaysia: a multi-method health systems appraisal approach , 2015, BMC Health Services Research.

[14]  K. Chinna,et al.  Validation of the Framingham general cardiovascular risk score in a multiethnic Asian population: a retrospective cohort study , 2015, BMJ Open.

[15]  S. Yusuf,et al.  Patients’ Knowledge, Attitudes, Behaviour and Health Care Experiences on the Prevention, Detection, Management and Control of Hypertension in Colombia: A Qualitative Study , 2015, PloS one.

[16]  R. Khatib.  Barriers to the management of cardiovascular disease , 2014 .

[17]  Joseph W Hogan,et al.  Optimizing linkage and retention to hypertension care in rural Kenya (LARK hypertension study): study protocol for a randomized controlled trial , 2014, Trials.

[18]  S. Yusuf,et al.  Patient and Healthcare Provider Barriers to Hypertension Awareness, Treatment and Follow Up: A Systematic Review and Meta-Analysis of Qualitative and Quantitative Studies , 2014, PloS one.

[19]  Gari D Clifford,et al.  A multifaceted strategy using mobile technology to assist rural primary healthcare doctors and frontline health workers in cardiovascular disease risk management: protocol for the SMARTHealth India cluster randomised controlled trial , 2013, Implementation Science.

[20]  C. Sánchis,et al.  Framingham Risk Score for Prediction of Cardiovascular Diseases: A Population-Based Study from Southern Europe , 2013, PloS one.

[21]  Martin McKee,et al.  Prevalence, awareness, treatment, and control of hypertension in rural and urban communities in high-, middle-, and low-income countries. , 2013, JAMA.

[22]  Pablo Perel,et al.  The Influence of Health Systems on Hypertension Awareness, Treatment, and Control: A Systematic Literature Review , 2013, PLoS medicine.

[23]  L. Cobos,et al.  [Latin American consensus on hypertension in patients with diabetes type 2 and metabolic syndrome]. , 2013, Clinica e investigacion en arteriosclerosis : publicacion oficial de la Sociedad Espanola de Arteriosclerosis.

[24]  S. Yusuf,et al.  Controversies in cardiovascular medicine Why are we failing to implement effective therapies in cardiovascular disease ? , 2013 .

[25]  B. Rompaey,et al.  Nurse-led interventions to enhance adherence to chronic medication: systematic review and meta-analysis of randomised controlled trials , 2013, European Journal of Clinical Pharmacology.

[26]  S. Yusuf,et al.  Comparison of Risk Factor Reduction and Tolerability of a Full-Dose Polypill (With Potassium) Versus Low-Dose Polypill (Polycap) in Individuals at High Risk of Cardiovascular Diseases: The Second Indian Polycap Study (TIPS-2) Investigators , 2012, Circulation. Cardiovascular quality and outcomes.

[27]  S. Yusuf,et al.  Use of secondary prevention drugs for cardiovascular disease in the community in high-income, middle-income, and low-income countries (the PURE Study): a prospective epidemiological survey , 2011, The Lancet.

[28]  P. Lindsay,et al.  Canadian Hypertension Education Program: the science supporting New 2011 CHEP recommendations with an emphasis on health advocacy and knowledge translation. , 2011, The Canadian journal of cardiology.

[29]  T. Novotny,et al.  UN resolution on the prevention and control of non-communicable diseases: An opportunity for global action , 2011, Global public health.

[30]  Zahi A Fayad,et al.  2010 ACCF/AHA guideline for assessment of cardiovascular risk in asymptomatic adults: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. , 2010, Journal of the American College of Cardiology.

[31]  A. Efron,et al.  Randomized controlled trial of trained patient-nominated treatment supporters providing partial directly observed antiretroviral therapy , 2010, AIDS.

[32]  D. Moher,et al.  CONSORT 2010 statement: Updated guidelines for reporting parallel group randomised trials , 2010, Journal of pharmacology & pharmacotherapeutics.

[33]  Salim Yusuf,et al.  The Prospective Urban Rural Epidemiology (PURE) study: examining the impact of societal influences on chronic noncommunicable diseases in low-, middle-, and high-income countries. , 2009, American heart journal.

[34]  L. Chambers,et al.  Comparison of Bayesian and classical methods in the analysis of cluster randomized controlled trials with a binary outcome: The Community Hypertension Assessment Trial (CHAT) , 2009, BMC medical research methodology.

[35]  T. Ahmed,et al.  Community-based skilled birth attendants in Bangladesh: attending deliveries at home , 2009, Reproductive health matters.

[36]  S. Nishtar,et al.  Can non-physician health-care workers assess and manage cardiovascular risk in primary care? , 2007, Bulletin of the World Health Organization.

[37]  A. Dominiczak,et al.  2007 Guidelines for the Management of Arterial Hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC) , 2007, European heart journal.

[38]  Piotr Ponikowski,et al.  2007 Guidelines for the management of arterial hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). , 2007, European heart journal.

[39]  M. Pfeffer,et al.  AHA/ACC guidelines for secondary prevention for patients with coronary and other atherosclerotic vascular disease: 2006 update endorsed by the National Heart, Lung, and Blood Institute. , 2006, Journal of the American College of Cardiology.

[40]  Alan D. Lopez,et al.  Global burden of disease and risk factors , 2006 .

[41]  E. Balas,et al.  Improving clinical practice using clinical decision support systems: a systematic review of trials to identify features critical to success , 2005, BMJ : British Medical Journal.

[42]  H. Mcdonald,et al.  Effects of computerized clinical decision support systems on practitioner performance and patient outcomes: a systematic review. , 2005, JAMA.

[43]  S. Yusuf,et al.  Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study , 2004, The Lancet.

[44]  G. Piaggio,et al.  Consort 2010 statement: extension to cluster randomised trials , 2012, BMJ : British Medical Journal.

[45]  D. Altman,et al.  CONSORT statement: extension to cluster randomised trials , 2004, BMJ : British Medical Journal.

[46]  K. Reynolds,et al.  Worldwide prevalence of hypertension: a systematic review , 2004, Journal of hypertension.

[47]  Daniel W. Jones,et al.  Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. , 2003, Hypertension.

[48]  N J Wald,et al.  Value of low dose combination treatment with blood pressure lowering drugs: analysis of 354 randomised trials , 2003, BMJ : British Medical Journal.

[49]  N J Wald,et al.  A strategy to reduce cardiovascular disease by more than 80% , 2003, BMJ : British Medical Journal.

[50]  R. Collins,et al.  Prevention of coronary and stroke events with atorvastatin in hypertensive patients who have average or lower-than-average cholesterol concentrations, in the Anglo-Scandinavian Cardiac Outcomes Trial—Lipid Lowering Arm (ASCOT-LLA): a multicentre randomised controlled trial , 2003, The Lancet.

[51]  J. Hardin,et al.  Generalized Estimating Equations , 2002 .

[52]  S. Yusuf.  Two decades of progress in preventing vascular disease , 2002, The Lancet.

[53]  M. Cabana,et al.  Why don't physicians follow clinical practice guidelines? A framework for improvement. , 1999, JAMA.

[54]  Joseph L Schafer,et al.  Analysis of Incomplete Multivariate Data , 1997 .

[55]  S. Mishra,et al.  Effectiveness of a lifestyle intervention led by female community health volunteers versus usual care in blood pressure reduction (COBIN): an open-label, cluster-randomised trial. , 2018, The Lancet. Global health.

[56]  B. Gersh.  Explaining the Decrease in U.S. Deaths from Coronary Disease, 1980–2000 , 2008 .

[57]  TAkING STOCk,et al.  Task shifting to tackle health worker shortages , 2007 .

[58]  N. P. Napalkov,et al.  for the prevention and control of noncommunicable diseases , 1999 .